The restrictive human BBB and GBMs molecular heterogeneity, with varied receptor expression (e.g., EGFR, CD44), necessitate personalized MSN designs, which are logistically difficult to implement
Glycine Soja (Soybean) Oil (68, 6%), Sorbeth-30 Tetraoleate, Polyethylene, Trihydroxystearin, Mentha Arvensis Leaf Oil, Melaleuca Alternifolia (Tea Tree) Leaf Oil, Tocopheryl Acetate, Helianthus Annuus (Sunflower) Seed Oil, Olea Europaea (Olive) Fruit Oil, Simmondsia Chinensis (Jojoba) Seed Oil, Oenothera Biennis (Evening Primrose) Oil, Glutathione, Niacinamide, Aqua, Limonene, Glycerin, Dipropylene Glycol, 1, 2-Hexanediol, Butylene Glycol, Squalane, Asiaticoside, Madecassic Acid, Asiatic Acid, Hippophae Rhamnoides Fruit Extract, Hydrolyzed Collagen, Beta-Glucan, Artemisia Annua Extract, Oryza Sativa (Rice) Extract, Nelumbo Nucifera Extract, Saccharomyces Ferment, Solanum Melongena (Eggplant) Fruit Extract, Melaleuca Alternifolia (Tea Tree) Leaf Extract Ingredients may change
FDA identified inconsistent naming and incomplete characterisation in the Epitalon compounding nominations it assessed
Functional recovery of rat hind-limb allografts